Investigation of the Potential Mechanism Governing the Effect of the on COVID-19 by Network Pharmacology

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2020 Nov 23

PMID 33224256

Citations 6

Authors

Yuxuan Wang

Yuhua Ru

Guowei Zhuo

Maozheng Sheng

Shuangqiu Wang

Jiarui Ma

Chongyi Zhou

Xiaohe Sun

Yanqi Zeng

Ya Zhang

Hui Li

Zhigang Lu

Depei Wu

Minghua Wu

Affiliations

Soon will be listed here.

Abstract

Background: Since December 2019, coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 infection has emerged in Wuhan and rapidly spread throughout China and even to other countries. Combined therapy with modern medicine and traditional Chinese medicine has been proposed, in which (SZS) was regarded as one of the basic prescriptions.

Methods: Network pharmacological approaches along with candidate compound screening, target prediction, target tissue location, protein-protein interaction network, gene ontology (GO), KEGG enrichment analyses, and gene microarray analyses were applied.

Results: A total of 627 targets of the 116 active ingredients of SZS were identified. Targets in immune cells and tissues were much more abundant than those in other tissues. A total of 597 targets were enriched in the GO biological cellular process, while 153 signaling pathways were enriched according to the KEGG analysis. A total of 450 SARS-related targets were integrated and intersected with the targets of SZS to identify 40 common targets that were significantly enriched in five immune function aspects of the immune system process during GO analysis. Several inflammation-related pathways were found to be significantly enriched throughout the study.

Conclusions: The therapeutic mechanisms of the effects of SZS on COVID-19 potentially involve four effects: suppressing cytokine storms, protecting the pulmonary alveolar-capillary barrier, regulating the immune response, and mediating cell death and survival.

Citing Articles

Identifying target organ location of Radix Achyranthis Bidentatae: a bioinformatics approach on active compounds and genes.

Tran M, Baek S, Jun H, Lee S Front Pharmacol. 2023; 14:1187896.

PMID: 37637410 PMC: 10448535. DOI: 10.3389/fphar.2023.1187896.

Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine.

Hu C Clin Complement Med Pharmacol. 2023; 3(3):100089.

PMID: 37342312 PMC: 10076251. DOI: 10.1016/j.ccmp.2023.100089.

Systems biology approach reveals a common molecular basis for COVID-19 and non-alcoholic fatty liver disease (NAFLD).

Jiang S, Liu Y, Zhang L, Sang X, Xu Y, Lu X Eur J Med Res. 2022; 27(1):251.

PMID: 36380355 PMC: 9664052. DOI: 10.1186/s40001-022-00865-y.

Active disease-related compound identification based on capsule network.

Yang B, Bao W, Wang J Brief Bioinform. 2022; 23(1).

PMID: 35057581 PMC: 8690041. DOI: 10.1093/bib/bbab462.

Potential Treatment of COVID-19 with Traditional Chinese Medicine: What Herbs Can Help Win the Battle with SARS-CoV-2?.

Li L, Wu Y, Wang J, Yan H, Lu J, Wang Y Engineering (Beijing). 2021; 19:139-152.

PMID: 34729244 PMC: 8552808. DOI: 10.1016/j.eng.2021.08.020.

References

Chen Z, Zhang C, Gao F, Fu Q, Fu C, He Y . A systematic review on the rhizome of Ligusticum chuanxiong Hort. (Chuanxiong). Food Chem Toxicol. 2018; 119:309-325. DOI: 10.1016/j.fct.2018.02.050. View

Mizutani T . Signal transduction in SARS-CoV-infected cells. Ann N Y Acad Sci. 2007; 1102:86-95. PMC: 7167675. DOI: 10.1196/annals.1408.006. View

Granado-Serrano A, Martin M, Bravo L, Goya L, Ramos S . Quercetin attenuates TNF-induced inflammation in hepatic cells by inhibiting the NF-κB pathway. Nutr Cancer. 2012; 64(4):588-98. DOI: 10.1080/01635581.2012.661513. View

Wang P, Dai L, Zhou W, Meng J, Zhang M, Wu Y . Intermodule Coupling Analysis of Huang-Lian-Jie-Du Decoction on Stroke. Front Pharmacol. 2019; 10:1288. PMC: 6848980. DOI: 10.3389/fphar.2019.01288. View

Kalil A, Thomas P . Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019; 23(1):258. PMC: 6642581. DOI: 10.1186/s13054-019-2539-x. View

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Channappanavar R, Zhao J, Perlman S . T cell-mediated immune response to respiratory coronaviruses. Immunol Res. 2014; 59(1-3):118-28. PMC: 4125530. DOI: 10.1007/s12026-014-8534-z. View

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

10.

Yang Y, Islam M, Wang J, Li Y, Chen X . Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. Int J Biol Sci. 2020; 16(10):1708-1717. PMC: 7098036. DOI: 10.7150/ijbs.45538. View

11.

Yang B, Wang H, Ma Z, Lu C, Li Y, Lu Z . A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19). Curr Med Sci. 2021; 41(2):297-305. PMC: 8056192. DOI: 10.1007/s11596-021-2346-x. View

12.

Gao L, Wang K, Zhou Y, Fang J, Qin X, Du G . Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation. Sci Rep. 2018; 8(1):624. PMC: 5766629. DOI: 10.1038/s41598-017-18325-7. View

13.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

14.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

15.

Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A . ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009; 25(8):1091-3. PMC: 2666812. DOI: 10.1093/bioinformatics/btp101. View

16.

Eng Y, Lee C, Lee W, Huang C, Chang J . Unraveling the Molecular Mechanism of Traditional Chinese Medicine: Formulas Against Acute Airway Viral Infections as Examples. Molecules. 2019; 24(19). PMC: 6804036. DOI: 10.3390/molecules24193505. View

17.

Bassetti M, Vena A, Giacobbe D . The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. Eur J Clin Invest. 2020; 50(3):e13209. PMC: 7163647. DOI: 10.1111/eci.13209. View

18.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

19.

Di Lorenzo A, Fernandez-Hernando C, Cirino G, Sessa W . Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc Natl Acad Sci U S A. 2009; 106(34):14552-7. PMC: 2732859. DOI: 10.1073/pnas.0904073106. View

20.

Li T, Peng T . Traditional Chinese herbal medicine as a source of molecules with antiviral activity. Antiviral Res. 2012; 97(1):1-9. PMC: 7114103. DOI: 10.1016/j.antiviral.2012.10.006. View